You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 149 No. 10, October 1989 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL INVESTIGATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Safety of Long-term Large Doses of Aspartame

Arthur S. Leon, MD; Donald B. Hunninghake, MD; Catherine Bell, MBA; David K. Rassin, PhD; Thomas R. Tephly, MD, PhD

Arch Intern Med. 1989;149(10):2318-2324.


Abstract

• Safety of long-term administration of 75 mg/kg of aspartame per day was evaluated with the use of a randomized, double-blind, placebo-controlled, parallel-group design in 108 male and female volunteers aged 18 to 62 years. Subjects received either aspartame or placebo in capsule form three times daily for 24 weeks. No persistent changes over time were noted in either group in vital signs; body weight; results of standard laboratory tests; fasting blood levels of aspartame's constituent amino acids (aspartic acid and phenylalanine), other amino acids, and methanol; or blood formate levels and 24-hour urinary excretion of formate. There also were no statistically significant differences between groups in the number of subjects experiencing symptoms or in the number of symptoms per subject. These results further document the safety of the long-term consumption of aspartame at doses equivalent to the amount of aspartame in approximately 10 L of beverage per day.

(Arch Intern Med. 1989;149:2318-2324)



Author Affiliations

From the Division of Epidemiology, School of Public Health (Dr Leon and Ms Bell) and Department of Medicine, Medical School (Drs Leon and Hunninghake), University of Minnesota, Minneapolis; Department of Pediatrics, University of Texas Medical Branch at Galveston (Dr Rassin); and Department of Pediatrics and Biochemistry, Medical School, University of Iowa, Iowa City (DrTephly).


Footnotes

Accepted for publication May 18, 1989.

Presented in part at the 1988 Annual Meeting of the Federation of American Societies for Experimental Biology, Las Vegas, Nev, May 2,1988.

Reprint requests to Division of Epidemiology, School of Public Health, University of Minnesota, Stadium Gate 27,611 Beacon St SE, Minneapolis, MN 55455 (Dr Leon).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Increased Urinary Calcium Excretion after Acute Aspartame Ingestion in Healthy Subjects--Authors' Response
Nguyen
J. Clin. Endocrinol. Metab. 1999;84:384-384.
FULL TEXT  

Unproven Diet Therapies in the Treatment of the Chronic Fatigue Syndrome
Morris and Stare
Arch Fam Med 1993;2:181-186.
ABSTRACT  

Review of Present and Future Use of Nonnutritive Sweeteners
Bertorelli and Czarnowski-Hill
The Diabetes Educator 1990;16:415-420.
 

THE SAFETY OF ASPARTAME
JWatch General 1989;1989:7-7.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.